http://www.medications.com/effect/view/38046 Post-marketing reports of neuropsychiatric events associated with montelukast, zafirlukast and zileuton have been reported to FDA’s Adverse Event Reporting System (AERS). Most of the reports of neuropsychiatric events are associated with montelukast, cur Sun, 15 Feb 2009 07:03:37 -0500 http://www.medications.com/effect/view/38046?item=17084 i to took my son off this drug a year ago,you are so not alone many of us have seen ,months later,what we refer to as "flashbacks" i have been in contact with the fda,and was told if they see a trend in reporting they will investigate perm damage,So i am http://www.medications.com/effect/view/38046?item=17084